Whitnell & Co’s Avanos Medical AVNS Stock Holding History

Whitnell & Co’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Hold	21	–	–	﹤0.01%	267
2019 Q3	$1K	Hold	21	–	–	﹤0.01%	266
2019 Q2	$1K	Hold	21	–	–	﹤0.01%	248
2019 Q1	$1K	Hold	21	–	–	﹤0.01%	252
2018 Q4	$1K	Hold	21	–	–	﹤0.01%	245
2018 Q3	$1K	Buy	+21	New	+$1.35K	﹤0.01%	247
2018 Q2	–	Sell	-21	Closed	-$1K	–	376
2018 Q1	$1K	Sell	21 -125	-86%	-$5.93K	﹤0.01%	381
2017 Q4	$7K	Hold	146	–	–	﹤0.01%	236
2017 Q3	$7K	Hold	146	–	–	﹤0.01%	219
2017 Q2	$6K	Hold	146	–	–	﹤0.01%	225
2017 Q1	$6K	Hold	146	–	–	﹤0.01%	236
2016 Q4	$5K	Hold	146	–	–	﹤0.01%	303
2016 Q3	$5K	Hold	146	–	–	﹤0.01%	292
2016 Q2	$5K	Hold	146	–	–	﹤0.01%	292
2016 Q1	$4K	Sell	146 -17	-10%	-$453	﹤0.01%	302
2015 Q4	$5K	Sell	163 -286	-64%	-$8.89K	﹤0.01%	298
2015 Q3	$13K	Sell	449 -498	-53%	-$17.4K	0.01%	220
2015 Q2	$38K	Sell	947 -3	-0.3%	-$135	0.01%	194
2015 Q1	$47K	Sell	950 -269	-22%	-$12.5K	0.02%	183
2014 Q4	$55K	Buy	+1,219	New	+$47.9K	0.02%	190

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Whitnell & Co's AVNS Position: Q4 2019 in Review

Whitnell & Co held its Avanos Medical (AVNS) position steady in Q4 2019 at 21 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Whitnell & Co first reported a position in AVNS in Q4 2014 and has held it in 20 quarters since. The position peaked at $55K in Q4 2014. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

Whitnell & Co held 21 shares of Avanos Medical worth $1K as of Q4 2019.
Whitnell & Co left its Avanos Medical share count unchanged in Q4 2019.
Avanos Medical made up ﹤0.01% of Whitnell & Co's portfolio in Q4 2019, its #267 holding.
Whitnell & Co first reported a position in Avanos Medical in Q4 2014 and has held it in 20 quarters since.
Whitnell & Co's Avanos Medical position peaked at $55K in Q4 2014.
293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.